Author:
Cho Byung-Sik,Min Gi-June,Park Sung-Su,Shin Seung-Hwan,Yahng Seung-Ah,Jeon Young-Woo,Yoon Jae-Ho,Lee Sung-Eun,Eom Ki-Seong,Kim Yoo-Jin,Lee Seok,Min Chang-Ki,Cho Seok-Goo,Kim Dong-Wook,Lee Jong-Wook,Kim Myungsin,Kim Younggu,Kim Hee-Je
Funder
Korea Health Industry Development Institute
Ministry of Health
Subject
Transplantation,Hematology
Reference45 articles.
1. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party;Schuurhuis;Blood,2018
2. Measurable residual disease testing in acute myeloid leukaemia;Hourigan;Leukemia,2017
3. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Dohner;Blood,2017
4. Aberrant phenotypes in acute myeloid leukemia: a high frequency and its clinical significance;Bahia;Haematologica,2001
5. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia;Zeleznikova;Neoplasma,2006
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献